TY - JOUR
T1 - The genetic profile of dysferlinopathy in a cohort of 209 cases
T2 - Genotype–phenotype relationship and a hotspot on the inner DysF domain
AU - Izumi, Rumiko
AU - Takahashi, Toshiaki
AU - Suzuki, Naoki
AU - Niihori, Tetsuya
AU - Ono, Hiroya
AU - Nakamura, Naoko
AU - Katada, Shinichi
AU - Kato, Masaaki
AU - Warita, Hitoshi
AU - Tateyama, Maki
AU - Aoki, Yoko
AU - Aoki, Masashi
N1 - Funding Information:
We thank the patients, their family, and their doctors for cooperation. We are grateful to Dr. Kazuhiro Kato for providing the sample and data and Chikako Yaginuma, Naoko Shimakura, Yoko Tateda, Kumi Kato, Riyo Takahashi, Maya Narisawa, and Hinako Shigihara for their technical assistance. We would like to thank Enago ( www.enago.jp ) for the English language review. We also acknowledge the support of the Biomedical Research Core of Tohoku University Graduate School of Medicine. This study was partially supported by Intramural Research Grant (29‐4) to M. A. and (29‐3) to T. T. for Neurological and Psychiatric Disorders provided from the National Center of Neurology and Psychiatry of Japan; The Practical Research Project for Rare/Diseases (15ek0109067h0002, 18dk0310086) provided to M. A. and (JP19ek0109259) provided to T. T. from the Japan Agency for Medical Research and Development (AMED); Grants‐in‐Aid for Research on Rare and Intractable Diseases (H26‐nanchitou(nan)‐ippan‐079, H29‐nanchitou(nan)‐ippan‐030, H30‐nanchitou(nan)‐ippan‐005) provided to M. A. from the Ministry of Health, Labour and Welfare of Japan; Grant‐in‐Aid for Challenging Exploratory Research (26670436, 18K19505) and Scientific Research B (16H05318) provided to M. A.; Young Scientists A (15H05667) and Scientific Research C (18K07519) provided to N. S.; Young Scientists (18K15437) provided to H. O. and Young Scientists B (17K16107) provided to R. I. This study was also supported by the Cooperative Research Project Program of the Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University.
Funding Information:
We thank the patients, their family, and their doctors for cooperation. We are grateful to Dr. Kazuhiro Kato for providing the sample and data and Chikako Yaginuma, Naoko Shimakura, Yoko Tateda, Kumi Kato, Riyo Takahashi, Maya Narisawa, and Hinako Shigihara for their technical assistance. We would like to thank Enago (www.enago.jp) for the English language review. We also acknowledge the support of the Biomedical Research Core of Tohoku University Graduate School of Medicine. This study was partially supported by Intramural Research Grant (29-4) to M. A. and (29-3) to T. T. for Neurological and Psychiatric Disorders provided from the National Center of Neurology and Psychiatry of Japan; The Practical Research Project for Rare/Diseases (15ek0109067h0002, 18dk0310086) provided to M. A. and (JP19ek0109259) provided to T. T. from the Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Research on Rare and Intractable Diseases (H26-nanchitou(nan)-ippan-079, H29-nanchitou(nan)-ippan-030, H30-nanchitou(nan)-ippan-005) provided to M. A. from the Ministry of Health, Labour and Welfare of Japan; Grant-in-Aid for Challenging Exploratory Research (26670436, 18K19505) and Scientific Research B (16H05318) provided to M. A.; Young Scientists A (15H05667) and Scientific Research C (18K07519) provided to N. S.; Young Scientists (18K15437) provided to H. O. and Young Scientists B (17K16107) provided to R. I. This study was also supported by the Cooperative Research Project Program of the Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University.
Publisher Copyright:
© 2020 Wiley Periodicals LLC
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Dysferlinopathy is a group of autosomal recessive muscular dystrophies caused by variants in the dysferlin gene (DYSF), with variable proximal and distal muscle involvement. We performed DYSF gene analyses of 200 cases suspected of having dysferlinopathy (Cohort 1), and identified diagnostic variants in 129/200 cases, including 19 novel variants. To achieve a comprehensive genetic profile of dysferlinopathy, we analyzed the variant data from 209 affected cases from unrelated 209 families, including 80 previously diagnosed and 129 newly diagnosed cases (Cohort 2). Among the 90 types of variants identified in 209 cases, the NM_003494.3: c.2997G>T; p.Trp999Cys, was the most frequent (96/420; 22.9%), followed by c.1566C>G; p.Tyr522* (45/420; 10.7%) on an allele base. p.Trp999Cys was found in 70/209 cases (33.5%), including 20/104 cases (19.2%) with the Miyoshi muscular phenotype and 43/82 cases (52.4%) with the limb-girdle phenotype. In the analysis of missense variants, p.Trp992Arg, p.Trp999Arg, p.Trp999Cys, p.Ser1000Phe, p.Arg1040Trp, and p.Arg1046His were located in the inner DysF domain, representing in 113/160 missense variants (70.6%). This large cohort highlighted the frequent missense variants located in the inner DysF domain as a hotspot for missense variants among our cohort of 209 cases (>95%, Japanese) and hinted at their potential as targets for future therapeutic strategies.
AB - Dysferlinopathy is a group of autosomal recessive muscular dystrophies caused by variants in the dysferlin gene (DYSF), with variable proximal and distal muscle involvement. We performed DYSF gene analyses of 200 cases suspected of having dysferlinopathy (Cohort 1), and identified diagnostic variants in 129/200 cases, including 19 novel variants. To achieve a comprehensive genetic profile of dysferlinopathy, we analyzed the variant data from 209 affected cases from unrelated 209 families, including 80 previously diagnosed and 129 newly diagnosed cases (Cohort 2). Among the 90 types of variants identified in 209 cases, the NM_003494.3: c.2997G>T; p.Trp999Cys, was the most frequent (96/420; 22.9%), followed by c.1566C>G; p.Tyr522* (45/420; 10.7%) on an allele base. p.Trp999Cys was found in 70/209 cases (33.5%), including 20/104 cases (19.2%) with the Miyoshi muscular phenotype and 43/82 cases (52.4%) with the limb-girdle phenotype. In the analysis of missense variants, p.Trp992Arg, p.Trp999Arg, p.Trp999Cys, p.Ser1000Phe, p.Arg1040Trp, and p.Arg1046His were located in the inner DysF domain, representing in 113/160 missense variants (70.6%). This large cohort highlighted the frequent missense variants located in the inner DysF domain as a hotspot for missense variants among our cohort of 209 cases (>95%, Japanese) and hinted at their potential as targets for future therapeutic strategies.
KW - Miyoshi muscular dystrophy
KW - arginine and tryptsophan (R/W) stacking
KW - dysferlin
KW - inner DysF domain
KW - limb-girdle muscular dystrophy type 2B
KW - next-generation sequencing
UR - http://www.scopus.com/inward/record.url?scp=85087437552&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087437552&partnerID=8YFLogxK
U2 - 10.1002/humu.24036
DO - 10.1002/humu.24036
M3 - Article
C2 - 32400077
AN - SCOPUS:85087437552
SN - 1059-7794
VL - 41
SP - 1540
EP - 1554
JO - Human Mutation
JF - Human Mutation
IS - 9
ER -